Mononuclear cells from the bone marrow of MDS patients revealed profound upregulation of caspase-1 (~ 209-fold) and NLRP3 (~ 48-fold) with no difference in caspase-3 expression. The gene discussed is NLRP3; the disease is myelodysplastic syndrome.